Publication | Closed Access

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

Neuro-oncologyPrognostic BiomarkersMedicinePathologyCancer GenomicsCell BiologyHigh-grade GliomasMolecular DiagnosticsGlioblastoma SurvivalOncologyGliomaTumor SuppressorTumor MicroenvironmentMolecular Profiling